Geron Corp. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Geron Corp.

GERN 1.120

+1.8%

Nov 21 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: LJM who wrote (3076)	5/14/2008 6:29:28 PM
From: Ron	of 3576

Hadn't watched GERN in awhile. With this kind of drop, the stock is getting interesting again. Back to 1998 prices.. --------- STEMCELL Technologies, Inc. and Geron Corporation (Nasdaq:GERN) today announced that Geron has granted a license to STEMCELL Technologies ("STEMCELL") under Geron intellectual property relating to primate pluripotent stem cells, including human embryonic stem cells. The non-exclusive license provides STEMCELL with rights under certain Geron patents to develop, manufacture and sell cell culture media and matrix surfaces for research use only. Geron will receive license payments and is entitled to royalties on sales of products developed under the license. Financial terms of the deal were not disclosed. The initial product covered by the license is STEMCELL's mTeSR(TM)1 medium (http://www.stemcell.com/product_catalog/undiffhumanes.aspx), which became available to the research community last June. mTeSR(TM)1 is the first commercially available feeder-independent, serum-free, defined maintenance medium for human embryonic stem cells. Financial details of the license agreement were not disclosed.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next